The peptide synthesis market is expanding rapidly, driven by the rising incidence of chronic diseases like cancer, diabetes, and cardiovascular conditions. This surge in demand is fueled by the ...

Granules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market ...

Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation ...

In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract ...

With this acquisition, Granules gains capabilities in high-growth peptide-based therapeutics. It also aims to enter the ...

Granules India acquires Senn Chemicals AG, expanding into peptide therapeutics and CDMO capabilities for global growth.

Hyderabad: Granules India Limited has announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss ...

Vapourtec’s R-Series flow chemistry system, equipped with a UV-150 photochemical reactor, has been cited in research by scientists* at Novo Nordisk in the C-terminal α-amination of peptides and ...

"The acquisition of Senn Chemicals AG marks a significant milestone in Granules' strategic growth journey” said Krishna ...

The Peptide-ExplorerLT ™ is designed for scientists who need to optimize and explore linear peptide synthesis. The product is a high-spec flow chemistry system that uses continuous flow. The product ...